Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Li Liu

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Journal of Clinical Psychopharmacology|June 23, 2011
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomerSheng-Chang Wang, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.
Omics : a Journal of Integrative Biology|September 11, 2013
Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohortSheng-Chang Wang, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Translational Psychiatry|July 18, 2024
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 13, 2012
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patientsSheng-Chang Wang, Hsiao-Hui Tsou, Chia-Hui Chen, et al.
Pharmacogenomics|June 9, 2012
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patientsJia-Ni Tian, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputationDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Translational Psychiatry|August 31, 2024
Correction: Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Plos One|April 6, 2012
Genome-wide association study of treatment refractory schizophrenia in Han ChineseYing-Jay Liou, Hui-Hung Wang, Ming-Ta Michael Lee, et al.
Psychiatric Genetics|January 6, 2006
Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese populationYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Journal of Clinical Psychopharmacology|June 23, 2011
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomerSheng-Chang Wang, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.
Omics : a Journal of Integrative Biology|September 11, 2013
Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohortSheng-Chang Wang, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Translational Psychiatry|July 18, 2024
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 13, 2012
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patientsSheng-Chang Wang, Hsiao-Hui Tsou, Chia-Hui Chen, et al.
Pharmacogenomics|June 9, 2012
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patientsJia-Ni Tian, Ing-Kang Ho, Hsiao-Hui Tsou, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputationDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Translational Psychiatry|August 31, 2024
Correction: Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Plos One|April 6, 2012
Genome-wide association study of treatment refractory schizophrenia in Han ChineseYing-Jay Liou, Hui-Hung Wang, Ming-Ta Michael Lee, et al.
Psychiatric Genetics|January 6, 2006
Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese populationYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Pageof 14